Our disease areas of focus
Our R&D approach of Science x Technology x Culture is helping to fight cancer on multiple groundbreaking fronts – immuno-oncology, cancer epigenetics, cell therapy, and synthetic lethality. Through this approach, GSK is developing solutions for some of the most challenging cancers, including multiple myeloma.
The ongoing DREAMM clinical trial program presented at ASH underscores our commitment to advancing research and improving patient outcomes for those living with blood cancer.
GSK at ASH
Our presentations at ASH 2020
Click here for more information regarding our participation in the virtual ASH Conference program
Our research areas of focus
We believe in a personalized approach to care that defines our research and development strategy.